GFAP

Whole-blood point-of-care glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 biomarkers after traumatic brain injury in the US: a prospective diagnostic prediction of intracranial injury on head CT

Study Overview The investigation centers on the utility of two specific biomarkers—glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase

Whole-blood point-of-care glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 biomarkers after traumatic brain injury in the US: a prospective diagnostic prediction of intracranial injury on head CT Read Post »

Whole-blood point-of-care glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 biomarkers after traumatic brain injury in the US: a prospective diagnostic prediction of intracranial injury on head CT

Biomarker Significance in Traumatic Brain Injury Traumatic brain injury (TBI) represents a significant public health challenge, often resulting in long-term

Whole-blood point-of-care glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 biomarkers after traumatic brain injury in the US: a prospective diagnostic prediction of intracranial injury on head CT Read Post »

Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account

Background on Biomarkers Biomarkers serve as vital indicators of biological processes, pathogenic processes, or pharmacologic responses to therapeutic interventions. In

Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account Read Post »

Response to: Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account

Study Overview The investigation into biomarkers for mild traumatic brain injury (mTBI) has garnered significant attention as the understanding of

Response to: Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account Read Post »

Scroll to Top